In another study on 101 advanced melanoma patients with decreased serum LDH after BRAF inhibitor treatment who completed all courses of ipilimumab, showed a significantly longer OS compared to those who did not (median OS 12.7 months vs. 1.2 months) [20]. Here, BRAF is linked to melanoma.